Liver transplantation for hepatocellular carcinoma-is there a risk of recurrence caused by intraoperative blood salvage autotransfusion?

European Surgical Research

Volumn 47, Issue 3, 2011, Pages 182-187

  Foltys, D ^a   Zimmermann, T ^b   Heise, M ^a   Kaths, M ^a   Lautem, A ^a   Wisser, G ^b   Weiler, N ^a   Hoppe Lotichius, M ^a   Hansen, T ^a   Otto, G ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Department of Internal Medicine i ^*  (Germany)

Author keywords

Hepatocellular carcinoma; Intraoperative blood salvage autotransfusion; Liver transplantation; Milan criteria; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; GRAFT RECIPIENT; HUMAN; INTRAOPERATIVE BLOOD SALVAGE AUTOTRANSFUSION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC CELLS, CIRCULATING; OPERATIVE BLOOD SALVAGE; RISK FACTORS;

EID: 80053506797     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000330746     Document Type: Article

References (34)

1. Hendriks HG, et al: Blood loss in orthotopic liver transplantation: a retrospective analysis of consecutive patients. Blood Coagul Fibrinolysis 2000; 11(suppl 1):S87-S93.
2. Phillips SD, et al: A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation. Transplantation 2006; 81: 536-540.
3. Houvenaeghel M, et al: Autologous transfusion by peroperative salvage in orthotopic transplantation of the liver (in French). Ann Fr Anesth Reanim 1989; 8: 326-333. (Pubitemid 19259161)
4. Autologous blood transfusions. Council on Scientific Affairs. JAMA 1986; 256: 2378-2380.
5. Otto G, et al: Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006; 12: 1260-1267. (Pubitemid 44194595)
6. Mazzaferro V, et al: Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008; 15: 1001-1007.
7. Margarit C, et al: Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002; 26: 257-263. (Pubitemid 36920440)
8. Yao FY, et al: Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774. (Pubitemid 35012284)
9. Mazzaferro V, et al: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
10. D'Amico F, et al: Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl 2009; 15: 1278-1287.
11. Shetty K, et al: Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10: 911-918. (Pubitemid 38979263)
12. Molmenti EP, Klintmalm GB: Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumour Registry. Liver Transpl 2002; 8: 736-748. (Pubitemid 35012281)
13. Todo S, Furukawa H: Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240: 451-459, discussion 459-461.
14. Tamura S, et al: Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136: 25-30, discussion 31.
15. Muscari F, et al: Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrencé Transpl Int 2005; 18: 1236-1239. (Pubitemid 41726743)
16. Francis DM: Relationship between blood transfusion and tumour behaviour. Br J Surg 1991; 78: 1420-1428.
17. Gharehbaghian A, et al: Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency. Lancet 2004; 363: 1025-1030. (Pubitemid 38410775)
18. Hansen E, Bechmann V, Altmeppen J: Intraoperative blood salvage with irradiation of blood in cancer surgery-answers to current queries (in German) . Anasthesiol Intensivmed Notfallmed Schmerzther 2002; 37: 740-744. (Pubitemid 36054991)
19. Yokoyama I, et al: Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991; 68: 2095-2100.
20. Foltys D, et al: Organ recipients suffering from undifferentiated neuroendocrine small-cell carcinoma of donor origin: a case report. Transplant Proc 2009; 41: 2639-2642.
21. Louha M, et al: Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 1997; 26: 998-1005. (Pubitemid 27413670)
22. Wang YL, et al: Analysis of alpha-fetoprotein mRNA level on the tumour cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation. Transplant Proc 2007; 39: 166-168.
23. Ijichi M, et al: alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology 2002; 35: 853-860. (Pubitemid 34258379)
24. Morimoto O, et al: Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood. Surg Today 2005; 35: 1033-1041. (Pubitemid 41772299)
25. Marubashi S, et al: Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation. Transplant Proc 2006; 38: 3640-3642. (Pubitemid 44908452)
26. Louha M, et al: Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells. Hepatology 1999; 29: 879-882. (Pubitemid 29109604)
27. Wong IH, et al: Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, nontumour liver and blood: implications in cancer detection and monitoring. Cancer Lett 2000; 156: 141-149. (Pubitemid 30394671)
28. Miyamoto A, et al: Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR. Int J Oncol 2001; 18: 527-532.
29. Waters JH, Donnenberg AD: Blood salvage and cancer surgery: should we do iẗ Transfusion 2009; 49: 2016-2018.
30. Elias D, Lapierre V, Billard V: Perioperative autotransfusion with salvage blood in cancer surgery (in French). Ann Fr Anesth Reanim 2000; 19: 739-744. (Pubitemid 32050079)
31. Hirano T, et al: Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today 2005; 35: 1042-1046. (Pubitemid 41772300)
32. Sotiropoulos GC, et al: Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition? Transplantation 2006; 81: 531-535.
33. Mion F, et al: Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 1996; 111: 1587-1592. (Pubitemid 26404223)
34. Bhartia B, et al: Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 2003; 180: 577-584. (Pubitemid 36237194)